Together with her research group, Malin Parmar has conducted several groundbreaking studies on stem cells that have led to the development of new treatments for patients with Parkinson’s disease. Using knowledge of how dopamine cells are normally formed as a starting point, researchers have mimicked this process in stem cells, thus creating new cells that can replace those that have been lost.
In its press release, The Royal Swedish Academy of Sciences further writes that Malin Parmar is a world-leading researcher in her field and has received several major national and international research grants. Among other achievements, last year the Swedish Research Council chose to appoint her to a so-called Council Professorship, an honour that comes with SEK 50 million in financial support over a ten-year period.
Karolinska Institutet’s Per Svenningsson was also elected to the Academy’s class for medical sciences at the same time as Malin Parmar.